ZA201508983B - Beta-casein a2 and prevention of inflammation of the bowel - Google Patents

Beta-casein a2 and prevention of inflammation of the bowel

Info

Publication number
ZA201508983B
ZA201508983B ZA2015/08983A ZA201508983A ZA201508983B ZA 201508983 B ZA201508983 B ZA 201508983B ZA 2015/08983 A ZA2015/08983 A ZA 2015/08983A ZA 201508983 A ZA201508983 A ZA 201508983A ZA 201508983 B ZA201508983 B ZA 201508983B
Authority
ZA
South Africa
Prior art keywords
casein
bowel
inflammation
beta
prevention
Prior art date
Application number
ZA2015/08983A
Other languages
English (en)
Inventor
Andrew John Clarke
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201508983(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of ZA201508983B publication Critical patent/ZA201508983B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2015/08983A 2013-05-31 2015-12-09 Beta-casein a2 and prevention of inflammation of the bowel ZA201508983B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361829764P 2013-05-31 2013-05-31
PCT/NZ2014/000102 WO2014193248A1 (en) 2013-05-31 2014-05-30 Beta-casein a2 and prevention of inflammation of the bowel

Publications (1)

Publication Number Publication Date
ZA201508983B true ZA201508983B (en) 2017-11-29

Family

ID=51989162

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/08983A ZA201508983B (en) 2013-05-31 2015-12-09 Beta-casein a2 and prevention of inflammation of the bowel

Country Status (19)

Country Link
US (2) US20160113997A1 (enExample)
EP (2) EP3003485B1 (enExample)
JP (2) JP6867158B2 (enExample)
KR (2) KR102282972B1 (enExample)
CN (2) CN112316116A (enExample)
AU (2) AU2014271423B2 (enExample)
BR (1) BR112015029987A8 (enExample)
CA (1) CA2913890C (enExample)
CL (1) CL2015003507A1 (enExample)
DK (1) DK3003485T3 (enExample)
ES (1) ES2742306T3 (enExample)
IL (2) IL242833B (enExample)
MX (2) MX367794B (enExample)
MY (1) MY179497A (enExample)
PH (2) PH12015502674B1 (enExample)
RU (1) RU2669553C2 (enExample)
SG (2) SG11201509769QA (enExample)
WO (1) WO2014193248A1 (enExample)
ZA (1) ZA201508983B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112316116A (zh) * 2013-05-31 2021-02-05 艾尔牛奶有限公司 β-酪蛋白A2和肠炎症的预防
AU2014287862B2 (en) * 2013-07-12 2019-07-11 The A2 Milk Company Limited Beta-casein A2 and reducing or preventing symptoms of lactose intolerance
GB2519101A (en) * 2013-10-09 2015-04-15 Nicoventures Holdings Ltd Electronic vapour provision system
CN106455662A (zh) * 2014-06-03 2017-02-22 雅培制药有限公司 包含亲脂性活性成分的营养组合物
MX392728B (es) * 2015-05-22 2025-03-24 A2 Milk Co Ltd Beta-caseina a2 y su capacidad antioxidante.
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
WO2017171563A1 (en) 2016-03-30 2017-10-05 The A2 Milk Company Limited Beta-caseins and cognitive function
WO2018063008A1 (en) * 2016-09-30 2018-04-05 The A2 Milk Company Limited Beta-caseins and gut microbiota
EP3526201B1 (en) * 2016-10-14 2020-11-18 H. Hoffnabb-La Roche Ag Imidazole compounds as eaat3 inhibitors
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN115708530B (zh) * 2022-11-15 2024-08-09 北大荒完达山乳业股份有限公司 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法
CN117322467A (zh) * 2023-10-11 2024-01-02 东北农业大学 A2β-酪蛋白在制备功能性食品中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442585T1 (de) 1994-11-04 2009-09-15 A2 Corp Ltd Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte
NZ306584A (en) * 1995-05-16 2000-02-28 Corran Norman Stuart Mclachlan Milk or dairy products derived from animals and which are free of beta casein
WO1996036239A1 (en) 1995-05-16 1996-11-21 Corran Norman Stuart Mclachlan Food product and process
US6570060B2 (en) 1995-05-16 2003-05-27 Mclachlan Corran Norman Stuart Milk lacking β-casein A1
AU4266100A (en) * 1995-05-16 2000-10-12 Corran Norman Stuart Mclachlan Food product and process
EP1196047A4 (en) * 1999-06-29 2004-12-22 New Zealand Milk Inst Ltd MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS
NZ516712A (en) * 1999-06-29 2003-10-31 New Zealand Milk Inst Ltd Prophylactic dietary supplement based on milk
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
CA2444470A1 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20060280802A1 (en) * 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
US7481127B2 (en) 2004-09-27 2009-01-27 Lester William T Continuously variable transmission using oscillating torque and one-way drives
KR20090083363A (ko) * 2006-10-06 2009-08-03 케리 그룹 서비스 인터내셔날 리미티드 우유 단백질 조성물 및 그 용도
US8871276B2 (en) * 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
CN112316116A (zh) * 2013-05-31 2021-02-05 艾尔牛奶有限公司 β-酪蛋白A2和肠炎症的预防
AU2014287862B2 (en) * 2013-07-12 2019-07-11 The A2 Milk Company Limited Beta-casein A2 and reducing or preventing symptoms of lactose intolerance

Also Published As

Publication number Publication date
DK3003485T3 (da) 2019-08-19
EP3003485A4 (en) 2016-11-30
EP3003485B1 (en) 2019-05-15
SG10201709509RA (en) 2017-12-28
IL242833B (en) 2019-07-31
CN105407971B (zh) 2020-11-17
JP7224242B2 (ja) 2023-02-17
WO2014193248A1 (en) 2014-12-04
KR20210094674A (ko) 2021-07-29
AU2014271423A1 (en) 2015-12-24
RU2015153113A (ru) 2017-07-05
AU2018274937A1 (en) 2019-01-03
JP2019165746A (ja) 2019-10-03
MX391963B (es) 2025-03-21
JP2016520611A (ja) 2016-07-14
HK1222362A1 (en) 2017-06-30
IL262302B (en) 2021-02-28
KR20160024884A (ko) 2016-03-07
AU2014271423B2 (en) 2018-12-20
IL262302A (en) 2018-11-29
MX367794B (es) 2019-09-06
KR102402455B1 (ko) 2022-05-25
RU2669553C2 (ru) 2018-10-12
EP3003485A1 (en) 2016-04-13
CA2913890A1 (en) 2014-12-04
MY179497A (en) 2020-11-09
RU2018131733A (ru) 2018-11-08
PH12015502674B1 (en) 2020-02-21
EP3542813A1 (en) 2019-09-25
BR112015029987A2 (pt) 2017-07-25
SG11201509769QA (en) 2015-12-30
CN112316116A (zh) 2021-02-05
PH12019550096A1 (en) 2020-02-10
JP6867158B2 (ja) 2021-04-28
MX2015016493A (es) 2016-08-18
ES2742306T3 (es) 2020-02-13
PH12015502674A1 (en) 2016-03-07
AU2018274937B2 (en) 2020-10-29
KR102282972B1 (ko) 2021-07-28
MX2019010594A (es) 2019-10-15
RU2018131733A3 (enExample) 2021-10-29
US11911439B2 (en) 2024-02-27
CN105407971A (zh) 2016-03-16
US20160113997A1 (en) 2016-04-28
US20200179485A1 (en) 2020-06-11
BR112015029987A8 (pt) 2021-12-07
NZ714912A (en) 2021-06-25
CL2015003507A1 (es) 2016-12-16
CA2913890C (en) 2024-09-10

Similar Documents

Publication Publication Date Title
IL262302B (en) Beta-casein a2 and prevention of intestinal inflammation
IL276113B (en) Electronic smoking part and electronic smoking device
TWI563902B (en) Mountable case and mountable case assembly
IL246116B (en) crispr-cas systems and their uses
SG10201710472PA (en) Combination of vaccination and inhibition of the pd-1 pathway
IL240518A0 (en) Capsule for single use and system
IL246221A0 (en) Endazoles and their uses
PL2968100T3 (pl) Kombinacje amidotiazoli alkilowych i konserwantów
IL246439A0 (en) Ring-linked morphines and their use
PT2972413T (pt) Anemómetro duplo flutuante - mastro e ultrassonografia doppler
GB201305277D0 (en) Novel combination and use
GB201305986D0 (en) Synthesis and use of isotopically-labelled glycans
IL244214A0 (en) Thienopiperidine derivative and its use
HUE049010T2 (hu) WC és WC-csésze
GB201310681D0 (en) Early Warning System and Prevention System
SG11201507389RA (en) Integration of hydro-dechlorination and hydro-regeneration
EP3041028A4 (en) LAMINATE AND ITS APPLICATION
GB201320992D0 (en) Complex and uses thereof
ZA201601880B (en) Hetero-transglycosylase and uses thereof
HUE060293T2 (hu) Annexin II variáns készítmények és eljárások
PL2975196T3 (pl) Element ścienny oraz kombinowany system utworzony z elementu ściennego i środka przenoszącego obciążenie
EP2957953A4 (en) CAMERA AND CAMERA ARRANGEMENT
GB201309180D0 (en) Compounds and Their Uses
TWI559919B (en) The uses of hydroxyl polymethoxylflavones and/or derivative thereof
GB201410957D0 (en) Lamp element and lamp